Advice and guidance

Guidance on endocrine disruptors

The European Food Safety Authority (EFSA) and the European Chemicals Agency (ECHA) are developing scientific guidance to enable identification of endocrine disruptors. In 2016 the European Commission proposed science-based criteria for identifying endocrine disruptors in the context of EU legislation on pesticides and biocides. Discussions with Member States and experts are on-going and the criteria […]

Guidance on endocrine disruptors Read More »

Resistant bacteria spreading in hospitals across Europe

Antibiotic resistance is widespread across the whole of Europe. High resistance, often seen in the southern and eastern countries of the European Union, is also found in the eastern part of the European Region. In particular, resistant bacteria are spreading in hospitals and health care settings, putting patients at risk of contracting incurable diseases. This

Resistant bacteria spreading in hospitals across Europe Read More »

Improving access to medicines

A new WHO report provides insight into how countries in the WHO European Region can improve access and reduce medicine prices through strategic and well-planned procurement processes. It also addresses collaboration within and across countries to improve availability of affordable medicines for patients in the Region. Countries in the Region have varying capacity and negotiating

Improving access to medicines Read More »

Sun-beds – no safe limit for UVR exposure

The final Opinion on the biological effects of ultraviolet radiation relevant to health with particular reference to sunbeds for cosmetic purposes has been published by the European Commission and its Scientific Committee on Health, Environmental and Emerging Risks (SCHEER). Ultraviolet Radiation (UVR), including that emitted by sunbeds, is considered a complete carcinogen, in that it

Sun-beds – no safe limit for UVR exposure Read More »

Scroll to Top